|
Characteristic Study ID |
Sex [female %] | Age [mean years (range)] | Ethnic groups [%] | Co‐medications / Co‐interventions | Co‐morbidities |
| Avenell 2012 | 85 | 77 | ‐ | ‐ | Low‐trauma osteoporotic fracture in the previous 10 years |
| Bolton‐Smith 2007 | 100 | 68 | ‐ | Vitamin K1 | ‐ |
| Brunner 2011 | 100 | 62.4 (50 to 79) | ‐ | ‐ | ‐ |
| Daly 2008 | 0 | 61.9 | ‐ | ‐ | ‐ |
| Gallagher 2001 | 100 | 71 (65 to 67) | ‐ | Conjugated oestrogens plus medroxyprogesterone acetate | ‐ |
| Glendenning 2012 | 100 | 76.7 | ‐ | ‐ | ‐ |
| Grady 1991 | 54 | 79.1 (70 to 97) | ‐ | ‐ | ‐ |
| Janssen 2010 | 100 | 80.8 | ‐ | ‐ | ‐ |
| Komulainen 1999 | 100 | 52.7 (47 to 56) | ‐ | Oestradiol valerate and cyproterone acetate | ‐ |
| Lappe 2007 | 100 | 66.7 | White: 100 | ‐ | ‐ |
| Larsen 2012 | 69 | 60 | White: 100 | Arterial hypertension | |
| Murdoch 2012 | 75 | 47 | ‐ | ‐ | ‐ |
| Ott 1989 | 100 | 67.5 (50 to 80) | ‐ | ‐ | ‐ |
| Prince 2008 | 100 | 77.2 (70 to 90) | ‐ | ‐ | ‐ |
| Sanders 2010 | 100 | 76 | ‐ | ‐ | ‐ |
| Trivedi 2003 | 24 | 74.7 (65 to 85) | ‐ | ‐ | ‐ |
| Witham 2013 | 48 | 77 (>70) | ‐ | ‐ | Arterial hypertension |
| Wood 2012 | 100 | 64 (60 to 70) | White: 100 | ‐ | ‐ |
| "‐" denotes not reported | |||||
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.